MOLECULIN BIOTECH INC MBRX
$2.64
-1.9% 52w: $1.96 – $20.90
Latest 13F among current holders filed 1 month ago (May 15, 2026)
Price — last 12 months
research preview data1.9611.4320.90
Jun 20, 2025 Jul 2, 2026
Institutional holders
20
+3 QoQ
13F value
$348K
+10.4% QoQ
Smart-money holders
0
signal tier ≥ 2
New smart buyers
0
Q1 2026
Institutional value by quarter
Number of holders
Who owns MBRX?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | Other | 75.0K | $172K | 3.0% | New |
| GEODE CAPITAL MANAGEMENT, LLC | Index provider | 32.3K | $74K | 0.0% | +113.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | Diversified mechanical | 13.9K | $32K | 0.0% | — |
| HRT FINANCIAL LP | Diversified mechanical | 13.7K | $31K | 0.0% | New |
| VANGUARD FIDUCIARY TRUST CO | Diversified mechanical | 6.1K | $14K | 0.0% | — |
| Rockefeller Capital Management L.P. | Diversified mechanical | 4.4K | $10K | 0.0% | +1928.0% |
| UBS Group AG | Bank broker | 3.4K | $8K | 0.0% | -41.9% |
| Tower Research Capital LLC (TRC) | Market maker | 1.8K | $4K | 0.0% | +31.7% |
| BlackRock, Inc. | Index provider | 491 | $1K | 0.0% | -0.8% |
| EFG International AG | Other | 434 | $994 | 0.0% | Held |
| Pinnacle Wealth Planning Services, Inc. | Other | 281 | $643 | 0.0% | Held |
| NFSG Corp | Diversified mechanical | 114 | $261 | 0.0% | Held |
| SBI Securities Co., Ltd. | Diversified mechanical | 43 | $98 | 0.0% | +48.3% |
| MORGAN STANLEY | Bank broker | 36 | $83 | 0.0% | Held |
| Vanguard Global Advisers, LLC | Diversified mechanical | 24 | $55 | 0.0% | — |
| FMR LLC | Long only active | 3 | $7 | 0.0% | New |
| DANSKE BANK A/S | Diversified mechanical | 2 | $5 | 0.0% | Held |
| Caitong International Asset Management Co., Ltd | Diversified mechanical | 2 | $5 | 0.0% | New |
| CVA Family Office, LLC | Wealth advisor | 1 | $2 | 0.0% | Held |
| OSAIC HOLDINGS, INC. | Wealth advisor | 1 | $2 | 0.0% | Held |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding MBRX
More healthcare stocks held by institutions